RecruitingNot ApplicableNCT06339996

Male Supplements for Sperm Quality and Aging

To Investigate Supplements for Improving Male Sperm Quality and Combating Aging


Sponsor

Kaohsiung Veterans General Hospital.

Enrollment

50 participants

Start Date

Mar 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study investigates the effects of a new supplement on sperm quality in men with poor sperm quality. Fifty patients will receive the supplement for three months, followed by semen analysis and assessment of sperm aging and mitochondrial function. Changes in sexual function and aging symptoms will also be evaluated.


Eligibility

Sex: MALEMin Age: 30 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Male supplement for people with unrecognized condition. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 30 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTMale supplement

Participants will be administered supplements for a three-month treatment period


Locations(1)

Kaohsiung Veterans General Hospital

Kaohsiung City, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06339996


Related Trials